Digestive & Liver Center

Digestive & Liver Center DLC offers full range of Gastroenterology and Liver Disease treatments. Dr. Tran obtained her M.D. degree from University of Kansas Medical School.

She completed her Internal Medicine internship and residency at University of Texas Health Science Center at Houston, TX. She completed Transplant Hepatology fellowship at Baylor College of Medicine in Houston, TX and subsequently completed Gastroenterology fellowship at the University of Missouri, Columbia, MO. Dr. Tran is board certified in Internal Medicine and Gastroenterology. Dr. Tran has an

active practice of patients with liver and digestive disease. Her clinical interests revolve around the optimal management of patients with chronic viral hepatitis B & C, Fatty liver, liver tumors, cirrhosis, advanced liver disease, liver cancer and liver transplantation. She is an active member of the American Association for the Study of Liver Disease and the American College of Gastroenterology.

*Fellowship in Gastroenterology - University of Missouri, Columbia, MO
*Fellowship in Hepatology and Liver Transplantation - Baylor College of Medicine, Houston, TX
*Internship and Residency in Internal Medicine - University of Texas Health Science Center at Houston, TX
*University of Kansas Medical School - M.D, Kansas City, Kansas

Withdrawal time in colonoscopy: one size does not fit allColonoscopy, the colorectal imaging test commonly used for prim...
04/28/2026

Withdrawal time in colonoscopy: one size does not fit all

Colonoscopy, the colorectal imaging test commonly used for primary colorectal cancer (CRC) screening, has been shown to reduce CRC incidence and prevent CRC mortality; however, its effectiveness depends highly on operator's technique, as well as on the quality of bowel preparation. Regarding operator's performance, quality is assessed through detection indicators such as adenoma detection rate (ADR), advanced ADR (AADR), number of conventional adenomas detected per colonoscopy in patients (APC), sessile serrated lesion detection rate (SSLDR), polyp detection rate (PDR), polyps per colonoscopy (PPC), and average withdrawal time (WT) in normal colonoscopies.1 ADR, defined as the percentage of patients aged ≥45 years undergoing colonoscopy for screening, surveillance, or diagnostic indications in whom at least 1 conventional adenoma is detected and pathologically confirmed, is considered the benchmark quality indicator. Currently, a minimum threshold of 35% for the ADR is recommended.1 Postcolonoscopy CRC (PCCRC) incidence and mortality decrease by approximately 3% and 5%, respectively, for every 1% increase in the ADR, and the risk continues to fall as ADR increases above 35%.2 Average WT includes the time needed to inspect the entire colon from the cecum to retroflexion in the re**um in normal colonoscopies with no polypectomy, biopsy sampling, or therapy. Although WT cannot replace ADR as the primary quality marker, longer WT has been correlated to higher ADR and consequently to lower PCCRC rates.3,4 Several studies have demonstrated that optimal adenoma detection typically requires at least 8 to 9 minutes to prevent PCCRC,4-6 leading to endorsement of 8 to 9 minutes as acceptable WT by current guidelines.

In this issue of Gastrointestinal Endoscopy, Taghiakbari et al,7 introduce for the first time corrected WT (cWT) as a quality marker in colonoscopy, cWT being the WT adjusted by subtracting intervention times. The authors further explore the time required for effective adenoma detection by prospectively evaluating cWT and WT in full-length video recordings of 1072 colonoscopy procedures. Using detailed statistical analysis, the authors determined the time required to achieve adequate ADR thresholds (≥26% and >35%) across different endoscopists’ performance levels and also assessed the impact of incremental increases in cWT and uncorrected WT on all key metrics (ADR, AADR, SSLDR, APC, PDR, and PPC). Similar adjusted WT measurements have been reported in prior studies.5 CWT offers a more precise measurement of actual inspection time, making it a truer reflection of endoscopist technique and inspection quality. To implicate, however, real-time calculation of cWT in everyday clinical practice presents several practical challenges. Unlike conventional WT, which can be measured automatically by most endoscopy processors, cWT requires real-time annotation and subtraction of the duration of specific therapeutic or cleaning interventions. In a busy endoscopy suite, this demands either additional personnel dedicated to timing and documentation, or the manual recording by the endoscopist or assisting nurse, tasks that can disrupt workflow. It is true that in the future, with artificial intelligence (AI) systems evolution, AI could interact with endoscopists and supply precise cWT calculations. However, in the present, consistent and accurate timing may vary widely across personnel and institutions, potentially undermining the reliability and reproducibility of cWT data. In this study, the authors have calculated that the mean of per-polyp intervention time was 1 minute 36 seconds across all procedures. Given that prolonged WT is a readily implementable measure requiring no additional technology or resources, this study provides evidence that cWT is a mean to improve ADR and induces the idea of appropriately calculating cWT by subtracting 1 minute 36 seconds per polyp to WT or for endoscopists who cannot routinely calculate cWT, to judge whether adequate WT is reached by adding 1 minute 36 seconds per removed polyp beyond the guideline-recommended 8 to 9 minutes.

As expected, cWT and WT prolongation improved ADR across all endoscopists irrespective of their experience level, with an average absolute ADR increase of 1.6% per additional minute of cWT. Current guidelines do not specify an appropriate WT when accounting for intervention time, and therapeutic interventions during withdrawal may mask true differences in inspection technique between high- and low-performing endoscopists. For this reason, the authors also analyzed cWT and WT separately by performance level (ADR

According to the National Comprehensive Cancer, at what age should colorectal screening start?30-35 (or 2-5 years before...
04/21/2026

According to the National Comprehensive Cancer, at what age should colorectal screening start?

30-35 (or 2-5 years before the earliest age of colon cancer in the family, if Dx before age 30)
40-45 (or 2-5 years before the earliest age of colon cancer in the family, if Dx before age 40)
36-39 (or 2-5 years before the earliest age of colon cancer in the family, if Dx before age 36)
45-49 (or 2-5 years before the earliest age of colon cancer in the family, if Dx before age 45)

Two-liter regimens are preferred over 4-L regimens as they improve patient tolerability while maintaining equivalent bow...
04/21/2026

Two-liter regimens are preferred over 4-L regimens as they improve patient tolerability while maintaining equivalent bowel cleansing efficacy (low risk for poor preparation).

Dietary restrictions can be limited to 1 day before colonoscopy using low-residue or low-fiber foods; clear-liquid–only diets are unnecessary for most outpatients at low risk for inadequate preparation.

Split-dose administration is recommended for all regimens; same-day dosing is acceptable only for afternoon procedures, with the second dose completed at least 2 hours before the procedure.

A preparation adequacy rate of 90% or greater is now recommended for both endoscopists and endoscopy units.

The US Multi-Society Task Force on Colorectal Cancer updated the 2014 consensus recommendations on colonoscopy preparation in 2025. For patients at low risk of inadequate preparation, key updates include simplifying dietary restrictions and using 2-L over 4-L regimens for improved tolerability while...

Appointments available. Top Liver Specialist in the area.Benefits of Digestive & Liver Consultation:Get Real Answers: Mo...
04/07/2026

Appointments available. Top Liver Specialist in the area.

Benefits of Digestive & Liver Consultation:

Get Real Answers: Move past guesswork and finally understand the root cause of your discomfort.

Expert Guidance: Speak directly with a specialist who understands the complexities of GI and liver health.

Early Detection: Identify potential health issues early on, when they are much easier to manage.

Peace of Mind: Stop worrying about your symptoms and start moving forward with a professional plan.

Digestive & Liver Center specializes in colon canccer screening, EGD esophagogastroduodenoscopy, and liver disease management.

Address

11100 WARNER Avenue SUITE 252
Fountain Valley, CA
92708

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17148674457

Alerts

Be the first to know and let us send you an email when Digestive & Liver Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Digestive & Liver Center:

Share

Category